AI assistant
Sending…
Nuvation Bio Inc. — Director's Dealing 2025
Jun 18, 2025
32154_dirs_2025-06-18_79009f16-d901-4ead-8893-06fb90b9cb40.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2025-06-16
Reporting Person: Wentworth Kerry (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-16 | Class A Common Stock | P | 26000 | $1.79 | Acquired | 26000 | Direct |
| 2025-06-16 | Class A Common Stock | P | 24000 | $1.8 | Acquired | 50000 | Direct |
More from Nuvation Bio Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4